Press Releases

"Made in Italy" material on concept vehicles, sportscars and luxury models

MILAN, May 23, 2024 /PRNewswire/ -- Alcantara, the global lifestyle brand, was featured on a number of vehicles shown at this year's Beijing Auto Show.

Hongqi's new Guoya, a luxury sedan, made its global debut with Alcantara-covered beige seating at the Beijing show (April... (continue reading...)

Company's Commitment, Including Dedicated Employee Resource Group and Custom Programming for Craft Workforce, Aims to Change the Way the Construction Industry Supports Employees

REDWOOD CITY, Calif., May 23, 2024 /PRNewswire/ -- DPR Construction, one of the nation's top technical builders, has been named to Newsweek's inaugural list of America's Greatest Workplaces for Mental Wellbeing. This recognition is presented by Newsweek and data researcher Plant-A.

SEASIDE, Ore., May 23, 2024 (GLOBE NEWSWIRE) -- From surfing to mountain biking, Seaside, Oregon is the destination to catch the perfect ride. The North Coast around Seaside is home to some of the Northwest’s best surfing beaches and offers a variety of surfing camps, lessons, and local surf shops. For riders who prefer dry ground, the 2024 Ride the Dirt Wave Flow Duro event returns to Klootchy Creek Trails in Seaside, June 8-9. This three-part mountain biking... (continue reading...)

IOWA CITY, Iowa, May 23, 2024 /PRNewswire/ - BEST Crowd Management ("BEST"), a GardaWorld company and a leading provider of crowd management and event security services, has been selected to provide guest and event security services to the University of Iowa, effective July 1, 2024.

As a result of this new agreement, BEST is hiring, with more than 500... (continue reading...)

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting.

REHOVOT, Israel, May 23, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced encouraging initial... (continue reading...)